Enhancing Care Through a Virtual Canadian Community of Practice for Managing Immune-Related Adverse Events.

ABSTRACT: The advent of immune checkpoint inhibitors (ICIs) has significantly transformed cancer treatment outcomes. However, these therapies can induce immune-related adverse events (irAEs) that may affect any organ system, sometimes requiring specialized expertise. As ICIs are increasingly used across various tumor types and in earlier treatment settings, not all practitioners have the necessary support network to handle complex irAEs. To address this gap, we collaborated with ONCOassist, a leading app for oncology professionals, to establish the first virtual Canadian Community of Practice (CoP) focused on irAEs. The CoP facilitates continuous learning and improves patient care among Canadian clinicians treating patients with immunotherapy by providing a platform for knowledge exchange and peer-t

SUBMITTER: Esfahani K 

PROVIDER: S-EPMC11941491 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature